Mutual Funds

ITI Pharma & Healthcare Fund-Reg(G)
Equity | Very High | Equity - Sectoral Fund - Pharma & Health Care

16.03 -0.01
NAV(₹) as on 5/12/2025

-0.04%
1D

-7.44%
1Y

18.31%
3Y

-
5Y

ITI Pharma & Healthcare Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio: 2.35	Launch Date: 08 Nov 2021
Exit Load: 0.50% on or before 3M, NIL after 3M	AUM: ₹ 232.83 Crs
Lock-in: Nil	Investing Style: Large Growth
Portfolio Price To Book Value: 8.02	Min. Investment: SIP : ₹ 500.0 Lumpsum : ₹ 5,000.0
Scheme Benchmark: NA
Fund Manager: Rohan Korde ,Dhimant Shah

FUND OBJECTIVE

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies engaged in Pharma and Healthcare.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

LATEST ASSET & PORTFOLIO ALLOCATION		Others		Equity
as on 31/10/2025		1.70 %		98.30 %

TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.

10.96 %

Divi's Laboratories Ltd.

8.97 %

Apollo Hospitals Enterprise Ltd.

6.35 %

Max Healthcare Institute Ltd.

5.71 %

Torrent Pharmaceuticals Ltd.

4.51 %

Cohance Lifesciences Ltd.

4.43 %

Fortis Healthcare Ltd.

3.98 %

Aurobindo Pharma Ltd.

3.70 %

Aster DM Healthcare Ltd.

3.62 %

Cipla Ltd.

3.07 %

See All Holding

ALLOCATION BY MARKET CAP (Equity)

ALLOCATION BY RATING (Debt & Others)

No Data

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs

69.11 %

Hospital & Healthcare Servic

22.62 %

Pesticides & Agrochemicals

2.07 %

Insurance

1.25 %

Engineering - Industrial Equ

1.05 %

See All Sectors

PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year	2021-22	2022-23	2023-24	2024-25
NAV (31/3/2025)	9.52	8.94	13.53	15.64
Net Assets (Rs Crores)	17,514.84	13,504.29	16,039.07	21,377.5
Scheme Returns(%)(Absolute)	-4.83	-6.09	51.05	14.23
B'mark Returns(%)(Absolute)	NA	NA	NA	NA
Category Rank	74/75	64/76	29/90	13/102

RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details	Inception Date	Aum(₹ Crs)	1Y	3Y	5Y	Since Inception
Kotak Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 13.51 +-0.01	11/12/2023	₹ 481.04	-3.81%	-	-	16.34%
Quant Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 15.00 +-0.11	17/7/2023	₹ 383.96	-7.47%	-	-	18.50%
HDFC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.37 +-0.05	4/10/2023	₹ 1,966.73	4.66%	-	-	29.14%
WOC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 14.02 +-0.04	6/2/2024	₹ 480.08	4.28%	-	-	20.27%
PGIM India Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.00 +-0.01	6/12/2024	₹ 106.92	-	-	-	%
Bajaj Finserv Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 9.80 +-0.03	27/12/2024	₹ 335.88	-	-	-	-2.02%
Baroda BNP Paribas Health and Wellness Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 9.58 +0.00	27/6/2025	₹ 621.16	-	-	-	-4.22%
ITI Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.03 +-0.01	8/11/2021	₹ 232.83	-7.44%	18.31%	-	12.27%
LIC MF Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 29.56 +-0.02	28/2/2019	₹ 86.0	-3.80%	19.39%	12.65%	17.35%
Aditya Birla SL Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 30.93 +-0.06	10/7/2019	₹ 847.28	-0.55%	20.20%	14.32%	19.26%